NCT05411718 2026-06-01A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch SyndromeM.D. Anderson Cancer CenterPhase 2 Recruiting40 enrolled